발행물

전체 논문

101

31

Generic atorvastatin and rosuvastatin in the South Korean market: time of introduction in relation to manufacturer characteristics
Son KB
Expert Review of Pharmacoeconomics & Outcomes Research (SSCI), 2020

32

Recent trends in tablet subdivision and factors affecting subdivision in South Korea: a cross sectional study
Son KB
Medicine (SCIE), 2020

33

Marketing and pricing strategies of blockbuster drugs in the South Korean market: a 15-year retrospective cohort study for choline alfoscerate
Park JW, Bae SJ, Lee TJ, Son KB (corresponding author)
Frontiers in Pharmacology (SCIE), 2020

34

Do free trade agreements matter to drug lag? Recent evidence from Korea after the Korea-U.S. Free Trade Agreement
Son KB
International Journal of Health Services (SSCI), 2020

35

Importance of the Intellectual Property System in Attempting Compulsory Licensing of Pharmaceuticals: A Cross-sectional Analysis
Son KB
Globalization and Health (SSCI), 2019

36

Public perceptions of the roles and functions of community pharmacies in the era of expanding scopes of pharmaceutical practice
Son KB, Choi SM, Kim DW
Health and Social Care in the Community (SSCI), 2019

37

Patterns of statin utilization for new users and market dynamics in South Korea: A 13-year Retrospective Cohort Study
Son KB, Bae SJ
BMJ Open (SCIE), 2019

38

Does the patent linkage system prolong effective market exclusivity? Recent evidence from the Korea-U.S. Free Trade Agreement in the Korean Market
Son KB, Bae SJ, Lee TJ
International Journal of Health Services (SSCI), 2019

39

Understanding of for Whom, Under What Conditions and How Compulsory Licensing of Pharmaceuticals Works in Brazil and Thailand: a Realist Synthesis
Son KB, Kim CY, Lee TJ
Global Public Health (SSCI), 2019

40

How much time before attempting compulsory licensing of pharmaceuticals? A non-parametric event history model with P-splines
Son KB
International Journal of Health Services (SSCI), 2019